CPhI South East Asia to open Thailand event in 2019
From 2019, CPhI South East Asia – organised by UBM – has announced it will alternate its annual location between the region’s two largest pharma economies, Indonesia and Thailand.
Leading science and technology company Merck (known as MilliporeSigma in the US) has announced agreements in China, India and South Korea that will see the company invest €40 million in the region.
The company has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon. Located on 10,141m2 of land, the new centre will include cell culture media facilities and a logistics infrastructure. Construction is expected to begin in May 2018 and to be completed by mid-2019.